Safety and Efficacy of AIR Inhaled Insulin Compared with Subcutaneous Insulin in Patients Having Diabetes and Asthma: A 12-Month, Randomized, Noninferiority Trial - Concepedia

Concepedia

Publication | Closed Access

Safety and Efficacy of AIR Inhaled Insulin Compared with Subcutaneous Insulin in Patients Having Diabetes and Asthma: A 12-Month, Randomized, Noninferiority Trial

10

Citations

28

References

2009

Year

Ernesto Ang, Mary K. Lawrence, Cory R. Heilmann, Jeffrey A. Ferguson, Janet Tobian, David Webb, Pierre‐Yves Berclaz

Diabetes Technology & Therapeutics

Abstract

In patients who have diabetes and asthma, AIR insulin demonstrated glycemic efficacy similar to SC insulin. Additionally, the safety profile of AIR insulin in patients with and without asthma is consistent.

References

	Year	Citations

Page 1